Originally presented at the PCRS Respiratory Conference 2020 Dr Glenis Scadding presents One airway: if they're wheezing, are they sneezing too?

NICE Diagnostic Guidance 12 (DG12); Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath.

Making a case for change In order to justify any investment on new services or equipment, it is important to make a case for change (business case), describe the intended impacts and outcomes of your project, and outline the costs and proj

Health Education England elearning for healthcare, in partnership with NHS England and NHS Improvement, Accelerated Access Collaborative, WAHSN, AHSN Network, and the Office for Life Sciences, developed two elearning modules focused on FeNO in Asthma.

NICE guidance is integral to the clinical care that we offer as Health Care Professionals (HCPs).

Quality Improvement (QI) helps us identify what works well and where we can make changes. In primary care, we don't have time or resources to spend on things that don't work, don't serve our patients, and that could be done more efficiently or effectively.

accuRx has created a FeNO template to send to patients prior to their appointment via text message. For information on what's included and how to find the template, have a look at the guidance document below.

This may include an understanding of the benefits of having a FeNO test, including:

Language can play a big barrier in healthcare delivery – for example, by preventing people accessing healthcare in an effectively and timely way, preventing people understand what they need to do to support their own self-management, or by preventing people from understanding their treatment and

These templates are only available to EMIS and TPP users – they are not available to MicroTest and Vision users.

March 2023 saw the first approval of a combination inhaled corticosteroid + long-acting beta2-agonist inhaler for the management of mild asthma in people over 12 years of age. The approval supports the move away from reliance on short-acting beta2-agonists which fa

Vaping can successfully help people address their tobacco dependence and reduce the long-term threats to their health from tobacco use.

There is still no sign of varenicline (Champix), a medication that can reduce nicotine cravings and help people quit smoking, 18 months after its approval was withdrawn in the UK due to concerns about impurities.

According to the Global Initiative for Asthma (GINA) asthma control is assessed in two domains: symptom control and risk of adverse outcomes.  Poor symptom control is budensome to patients and increases the risk of exacerbations, but patients with good symptom control can still have sev

Pulmonary rehabilitation (PR) improves quality of life and reduces exacerbations and NICE guidelines recommend that PR should be offered to all patients who consider themselves functionally disabled due to their COPD.